Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Oak Ridge National Laboratory scientists studied hot springs on different continents and found similarities in how some microbes adapted despite their geographic diversity.
Michelle Kidder, a senior R&D staff scientist at ORNL, has received the American Chemical Society’s Energy and Fuels Division’s Mid-Career Award for sustained and distinguished contributions to the field of energy and fuel chemistry.
Leigh R. Martin, a senior scientist and leader of the Fuel Cycle Chemical Technology group at ORNL, has been named a Fellow of the American Chemical Society for 2023.
Seven entrepreneurs will embark on a two-year fellowship as the seventh cohort of Innovation Crossroads kicks off this month at ORNL. Representing a range of transformative energy technologies, Cohort 7 is a diverse class of innovators with promising new companies.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.
An innovative and sustainable chemistry developed at ORNL for capturing carbon dioxide has been licensed to Holocene, a Knoxville-based startup focused on designing and building plants that remove carbon dioxide
When reading the novel Jurassic Park as a teenager, Jerry Parks found the passages about gene sequencing and supercomputers fascinating, but never imagined he might someday pursue such futuristic-sounding science.
Xiao-Ying Yu, a distinguished scientist in the Materials Science and Technology Division of the Department of Energy’s Oak Ridge National Laboratory, has recently been chosen for several prominent editorial roles.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.